<?xml version="1.0" encoding="utf-8"?><!DOCTYPE article PUBLIC "-//ES//DTD journal article DTD version 5.0.2//EN//XML" "art502.dtd" [<!ENTITY gr1 SYSTEM "gr1" NDATA IMAGE><!ENTITY gr2a SYSTEM "gr2a" NDATA IMAGE><!ENTITY gr2bc SYSTEM "gr2bc" NDATA IMAGE><!ENTITY gr3 SYSTEM "gr3" NDATA IMAGE><!ENTITY gr4 SYSTEM "gr4" NDATA IMAGE>]><article docsubtype="sco" xml:lang="en"><ce:floats xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:figure id="fig1"><ce:label>Fig. 1</ce:label><ce:caption><ce:simple-para>Radixin N-ERMAD interacts with the integrin <ce:bold><ce:italic>β</ce:italic></ce:bold> cytoplasmic tail. (A) Radixin N-ERMAD recognizes the β<ce:inf>2</ce:inf> cytoplasmic domain. A 96-well plate was coated with either the α<ce:inf>M</ce:inf> (∘, ▵) or β<ce:inf>2</ce:inf> cytoplasmic peptides (•, ▴), blocked, and then incubated with GST-radixin N-ERMAD (∘, •) or GST-C-ERMAD (▵, ▴). After washing, bound proteins were determined. (B) Radixin C-ERMAD blocks N-ERMAD binding to the β<ce:inf>2</ce:inf> cytoplasmic tail. Binding of radixin N-ERMAD to the α<ce:inf>M</ce:inf> (filled bar) or β<ce:inf>2</ce:inf> (open bar) peptides were conducted as described above, except that different concentrations of His-tagged radixin C-ERMAD were added. Data are means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>S.D. of duplicate samples and are representative of three independent experiments.</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Fig. 2</ce:label><ce:caption><ce:simple-para>Radixin recognizes the membrane-proximal region of the integrin <ce:bold><ce:italic>β</ce:italic></ce:bold><ce:inf>2</ce:inf> cytoplasmic tail. (A) The sequence of the β<ce:inf>2</ce:inf> cytoplasmic peptides. (B) Radixin N-ERMAD binds to the membrane-proximal region of the β<ce:inf>2</ce:inf> cytoplasmic tail. Interaction between the different β<ce:inf>2</ce:inf> cytoplasmic peptides and radixin N-ERMAD were determined by ELISA as above. (C) Inhibition of N-ERMAD binding to the β<ce:inf>2</ce:inf> cytoplasmic peptide by CTΔ31. Radixin N-ERMAD binding to the β<ce:inf>2</ce:inf> cytoplasmic tail was performed as above, except in the presence different soluble peptides. Data are means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>S.D. of duplicate samples and are representative of two independent experiments. sCTΔ31, scrambled CTΔ31.</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Fig. 3</ce:label><ce:caption><ce:simple-para>Cytohesin-1 and radixin N-ERMAD recognize overlapping regions of the β<ce:inf>2</ce:inf> cytoplasmic tail. (A) Cytohesin-1 binding to the β<ce:inf>2</ce:inf> cytoplasmic tail. His-cytohesin-1 binding to the β<ce:inf>2</ce:inf> cytoplasmic tail in the presence of different β<ce:inf>2</ce:inf> peptides was performed as above. (B) Competition between Cytohesin-1 and radixin. Binding of GST-radixin N-ERMAD to the β<ce:inf>2</ce:inf> cytoplasmic tail was conducted as in <ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref> except in the presence of His-tagged cytohesin-1 (□) or a control protein BSA (∘). Data are means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>S.D. of duplicate samples and are representative of two independent experiments.</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure><ce:figure id="fig4"><ce:label>Fig. 4</ce:label><ce:caption><ce:simple-para>Expression of the N-terminal radixin promotes integrin adhesive activity. (A) Pull-down assays. Cell lysates from α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-expressing CHO cells were passed through either GST-N-ERMAD (lanes 1 and 3) or GST (lanes 2 and 4)-column. After washing, the bound proteins were analyzed by SDS–PAGE and immunoblotted with anti-β<ce:inf>2</ce:inf> cytoplasmic tail (lanes 1 and 2) or anti-GST (lanes 3 and 4). (B) The effect of radixin N-ERMAD on cell adhesion. Different radixin fragments were expressed in α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>/CHO cells and their adhesion to the Fg γ-module (10<ce:hsp sp="0.25"/>μg/ml) was determined in the presence or absence of an α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-specific inhibitor NIF (10<ce:hsp sp="0.25"/>nM). After washing, representative adherent cells were photographed with 20× differential interference contrast (DIC) lens using the Zeiss Axiovert 200M system. Scale bars: 20<ce:hsp sp="0.25"/>μm. (C) The numbers of adherent cells in (B) were quantified by staining with Crystal violet and measuring absorption at 570<ce:hsp sp="0.25"/>nm. The specificity of the adhesion assay was confirmed by lack of cell adhesion of mock transfected cells. (D) Conformational changes within the α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> receptor. α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>/CHO cells expressing either N-ERMAD or GFP were incubated with 1<ce:hsp sp="0.25"/>μg of mAb 24 at 37<ce:hsp sp="0.25"/>°C or 2LPM19c in the presence of 1<ce:hsp sp="0.25"/>mM Ca<ce:sup>2+</ce:sup>/1<ce:hsp sp="0.25"/>mM Mg<ce:sup>2+</ce:sup> for 30<ce:hsp sp="0.25"/>min. Bound mAb 24 or 2LPM19c was determined by flow cytometry using R-Phycoerythrin conjugated anti-mouse IgG. An isotype matched non-immune IgG was used as a control (not shown). Mean fluorescence intensity of mAb 24, calculated using a FACScan program (BD Biosciences, Mountain View, CA) and normalized by surface expression of the receptor (based on 2LPM19c staining), was used as an activation index. N-ERMAD-expressing α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>/CHO cells exhibited significantly higher mAb 24 binding compared to those expressing GFP (∗, <ce:italic>P</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.002). Data are means<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>S.D. of duplicate samples and are representative of three independent experiments.</ce:simple-para></ce:caption><ce:link locator="gr4"/></ce:figure><ce:figure id="fig5"><ce:label>Fig. 5</ce:label><ce:caption><ce:simple-para>The integrin <ce:bold><ce:italic>β</ce:italic></ce:bold><ce:inf>2</ce:inf> cytoplasmic domain binding site within the radixin FERM domain. (A) Sequence alignment between the cytoplasmic domains of ICAM-2 and integrin β<ce:inf>2</ce:inf>. Functional residues that are conserved between these two proteins are shown in boxes. (B) The β<ce:inf>2</ce:inf> binding site within the radixin FERM domain. A schematic drawing of the β<ce:inf>2</ce:inf> cytoplasmic tail/radixin FERM complex was prepared from the crystal structure of the radixin/ICAM-2 complex <ce:cross-ref refid="bib22">[22]</ce:cross-ref>. The β<ce:inf>2</ce:inf> peptide is represented in red. The radixin FERM domain is composed of three subdomains: Fl (in cyan), F2 (in orange) and F3 (in green). The conserved residues are shown in balls and sticks.</ce:simple-para></ce:caption><ce:link locator="gr5"/></ce:figure></ce:floats><head><ce:title xmlns:ce="http://www.elsevier.com/xml/common/dtd">Cytoskeletal protein radixin activates integrin α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> by binding to its cytoplasmic tail</ce:title><ce:presented xmlns:ce="http://www.elsevier.com/xml/common/dtd">Edited by Gianni Cesareni</ce:presented><ce:author-group xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:author><ce:given-name>Pingtao</ce:given-name><ce:surname>Tang</ce:surname></ce:author><ce:author><ce:given-name>Chunzhang</ce:given-name><ce:surname>Cao</ce:surname></ce:author><ce:author><ce:given-name>Min</ce:given-name><ce:surname>Xu</ce:surname></ce:author><ce:author><ce:given-name>Li</ce:given-name><ce:surname>Zhang</ce:surname><ce:cross-ref refid="cor1"><ce:sup>⁎</ce:sup></ce:cross-ref><ce:e-address type="email">lizhang@som.umaryland.edu</ce:e-address></ce:author><ce:affiliation><ce:textfn>Center for Vascular and Inflammatory Diseases, Department of Physiology, University of Maryland School of Medicine, 800 W Baltimore Street, Baltimore, MD 21201, USA</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>⁎</ce:label><ce:text>Corresponding author. Fax: +1 410 706 8121.</ce:text></ce:correspondence></ce:author-group><ce:abstract class="author" xml:lang="en" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Talin binding of integrins, via its band 4.1, ezrin, radixin, and moesin (FERM)-homologous domain, directly activates the integrin receptor. However, it is not known whether other FERM-containing proteins also possess such an integrin activating capability. We report here that radixin, one of the original FERM-domain proteins, binds to the membrane-proximal region of the integrin β<ce:inf>2</ce:inf> but not α<ce:inf>M</ce:inf> cytoplasmic tail. Importantly, we show that radixin binding significantly enhances the adhesive activity of integrin α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>. Given the distinct biological activities of radixin and talin, radixin may represent a novel talin-independent pathway for integrin activation under specific settings.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords class="abr" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Abbreviations</ce:section-title><ce:keyword><ce:text>C-ERMAD</ce:text><ce:keyword><ce:text>C-terminal ezrin–radixin–moesin family (ERM) associated domain</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>CHO</ce:text><ce:keyword><ce:text>Chinese hamster cells</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>ERM</ce:text><ce:keyword><ce:text>the ezrin–radixin–moesin protein family</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>ERMAD</ce:text><ce:keyword><ce:text>ERM-associated domain</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>FERM</ce:text><ce:keyword><ce:text>the band 4.1, ezrin, radixin, and moesin-homologous domain</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>Fg</ce:text><ce:keyword><ce:text>fibrinogen</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>GFP</ce:text><ce:keyword><ce:text>green fluorescent protein</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>HRP</ce:text><ce:keyword><ce:text>horseradish peroxidase</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>ICAM-1</ce:text><ce:keyword><ce:text>intercellular adhesion molecule-1</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>N-ERMAD</ce:text><ce:keyword><ce:text>N-terminal ezrin–radixin–moesin family (ERM) associated domain</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>PBS</ce:text><ce:keyword><ce:text>phosphate buffered saline</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>PTB</ce:text><ce:keyword><ce:text>phosphotyrosine binding domain</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>GST</ce:text><ce:keyword><ce:text>glutathione-<ce:italic>s</ce:italic>-transferase</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>SDS–PAGE</ce:text><ce:keyword><ce:text>sodium dodecyl sulfate polyacrylamide gel electrophoresis</ce:text></ce:keyword></ce:keyword></ce:keywords><ce:keywords class="keyword" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Cell adhesion</ce:text></ce:keyword><ce:keyword><ce:text>Integrin</ce:text></ce:keyword><ce:keyword><ce:text>The band 4.1, ezrin, radixin, and moesin-homologous domain</ce:text></ce:keyword><ce:keyword><ce:text>Cytoskeleton</ce:text></ce:keyword></ce:keywords></head><body><ce:sections xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section><ce:label>1</ce:label><ce:section-title>Introduction</ce:section-title><ce:para>Recent studies suggest that talin binding to the cytoplasmic domain of integrin receptors represents the final step in integrin activation (“inside-out” signaling) <ce:cross-ref refid="bib1">[1]</ce:cross-ref>. Talin comprises of an N-terminal 50-kDa head region that is homologous to the FERM domain, and a C-terminal 205-kDa rod region, which regulates the function of the N-terminal head via intra- and inter-molecular interactions. Talin can be activated by calpain-mediated proteolysis <ce:cross-ref refid="bib2">[2]</ce:cross-ref> or by phosphoinositide binding <ce:cross-ref refid="bib3">[3]</ce:cross-ref>, and once activated, it binds, through the phosphotyrosine binding (PTB) domain located within its FERM-homologous region, to a highly conserved NPxY motif within the integrin β cytoplasmic tail <ce:cross-refs refid="bib4 bib5">[4,5]</ce:cross-refs>. Integrin engagement by talin subsequently disrupts a salt bridge between its α and β cytoplasmic domains <ce:cross-ref refid="bib6">[6]</ce:cross-ref>, leading to its activation <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. Interestingly, although a number of proteins, including syk, Numb, and Dok, contain a PTB domain that interacts with the integrin β cytoplasmic tail with high affinity, however, none of them was capable of activating integrin receptor <ce:cross-ref refid="bib5">[5]</ce:cross-ref>. Thus, the talin FERM domain seems very unique in its integrin activating capability.</ce:para><ce:para>In this study, we searched for additional proteins that are capable of activating integrins. We report here the identification of another FERM protein radixin that possesses similar integrin activating activities. Using α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> (Mac-1, CD11b/CD18) as a representative of integrin receptors, we demonstrate that radixin binds to the membrane-proximal region of the integrin β cytoplasmic tail via its N-terminal ezrin–radixin–moesin family (ERM) associated domain (N-ERMAD). We show that radixin binding to integrin α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> enhances its adhesive activity. Together, our study identifies radixin as an important player in integrin “inside-out” signaling in addition to talin. As radixin recognizes the integrin cytoplasmic tail differently than talin, radixin may represent a novel talin-independent pathway for integrin activation under specific settings.</ce:para></ce:section><ce:section role="materials-methods"><ce:label>2</ce:label><ce:section-title>Materials and methods</ce:section-title><ce:section><ce:label>2.1</ce:label><ce:section-title>Materials</ce:section-title><ce:para>MGIN <ce:cross-ref refid="bib7">[7]</ce:cross-ref> was provided by Dr. R.G. Hawley (American Red Cross, Rockville, MD). IB4, OKM1, and TS1/18 were from ATCC (Rockville, MD); mAb 44 and 2LPM19c were from Sigma (St. Louis, MO). mAb 24 <ce:cross-ref refid="bib8">[8]</ce:cross-ref> was provided by Dr. Nancy Hogg (Imperial Cancer Research Fund, London, UK). Recombinant γ-module of fibrinogen (Fg) was provided by Dr. L. Medved (University of Maryland, MD). Neutrophil inhibitor factor (NIF) <ce:cross-ref refid="bib9">[9]</ce:cross-ref> was provided by Dr. E. Plow (Cleveland Clinic Foundation, OH). All other reagents were of the highest grade available from Sigma Chemical Co. (St Louis, MO) unless otherwise noted.</ce:para></ce:section><ce:section><ce:label>2.2</ce:label><ce:section-title>Expression of recombinant radixin in <ce:italic>E. coli</ce:italic></ce:section-title><ce:para>To express the radixin N-ERMAD (1–298) and C-ERMAD (281–584) in <ce:italic>E. coli</ce:italic>, their corresponding cDNAs were amplified using the following pairs of primers: 5′-AAAGGATCC-ATGCCGAAGCCAATCAATGTAAGAGT-3′ and 5′-TCAGTCGACTT-AATCAGGCTTTCTCCTTCGCATGTACAG-3′, and 5′-AAAGGATCCTTGGCCTTATGTATGG-GAAACATGAA-3′ and 5′-GAAGTCGACTCACATGGCTTCAAACTCATCGATGCG-3′, and then cloned into pGEX-4T-1 (for glutathione-<ce:italic>s</ce:italic>-transferase (GST) fusion; Amersham, Piscataway, NJ) and pET-32a (for histidine-tag fusion; Novagen, Madison, WI). Cytohesin-1 was expressed as a histidine-tagged protein using pQE-31 (QIAgen). Generation of recombinant proteins in <ce:italic>E. coli</ce:italic> BL21(DE3) and their purification using the glutathione–Sepharose or Ni–NTA column have been described previously <ce:cross-ref refid="bib9">[9]</ce:cross-ref>. The concentrations of the purified proteins were determined spectrophotometrically using the equation C (mg/ml)<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>(A280–A320)/1.45 and the concentrations were further verified by Coomassie blue-stained SDS–PAGE using BSA as a standard.</ce:para></ce:section><ce:section><ce:label>2.3</ce:label><ce:section-title>Binding assays by ELISA</ce:section-title><ce:para>Ninety six-well polystyrene microtiter plates (Costar, Corning, NY) were coated with different synthetic peptides (1<ce:hsp sp="0.25"/>mg/ml) overnight at 4<ce:hsp sp="0.25"/>°C and post-coated with 10% milk for 1<ce:hsp sp="0.25"/>h at room temperature. GST-tagged radixin fragments or His-tagged cytohesin-1 (both at 150<ce:hsp sp="0.25"/>nM) in phosphate buffered saline (PBS) plus 0.1%BSA were added and incubated for 40<ce:hsp sp="0.25"/>min at room temperature. After washing with PBS, bound GST-radixin was detected using a horseradish peroxidase (HRP)-anti-GST conjugate, and an HRP substrate 3,3′,5,5′-tetramethylbenzidine, measuring absorption at 550<ce:hsp sp="0.25"/>nm (<ce:italic>A</ce:italic><ce:inf>550</ce:inf>).</ce:para></ce:section><ce:section><ce:label>2.4</ce:label><ce:section-title>Pull down assays</ce:section-title><ce:para>Cells expressing α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>, which were established previously <ce:cross-ref refid="bib10">[10]</ce:cross-ref>, were lysed in 20<ce:hsp sp="0.25"/>mM Tris–HCl, 150<ce:hsp sp="0.25"/>mM NaCl, pH 7.4, 0.25% deoxycholate, 1% <ce:italic>p</ce:italic>-nitrophenyl-<ce:italic>p</ce:italic>-guanidinobezoate, 2<ce:hsp sp="0.25"/>mM EGTA, 1<ce:hsp sp="0.25"/>mM PMSF, 10<ce:hsp sp="0.25"/>mM benzamidine, 25<ce:hsp sp="0.25"/>μg/ml SBTI, and 20<ce:hsp sp="0.25"/>μg/ml leupeptin. After centrifugation, cell lysates were incubated with GST-radixin N-ERMAD that was immobilized onto a glutathione agarose column. After washing, bound proteins were eluted and then analyzed by 10% SDS–PAGE. The presence of α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> was detected by immunobloting using an anti-β<ce:inf>2</ce:inf> cytoplasmic domain antibody <ce:cross-ref refid="bib11">[11]</ce:cross-ref> and visualized using an HRP conjugate of goat anti-rabbit IgG.</ce:para></ce:section><ce:section><ce:label>2.5</ce:label><ce:section-title>Establishment of Chinese hamster cells (CHO) expressing both integrin α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> and radixin</ce:section-title><ce:para>To express α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> and radixin simultaneously, cDNAs encoding N-ERMAD and C-ERMAD were inserted individually into the expression vector MGIN <ce:cross-ref refid="bib7">[7]</ce:cross-ref>, in which radixin expression is tightly linked to green fluorescent protein (GFP) expression via an internal ribosome entry site (IRES). These expression plasmids were transfected, together with a expression vector containing the hygromycin cDNA, into the α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-expressing CHO cells that we previously established <ce:cross-ref refid="bib10">[10]</ce:cross-ref>. After selection with 200<ce:hsp sp="0.25"/>μg/ml hygromycin, stable clones that express equivalent amount of α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> and radixin were established by dual-color cell sorting using a mAb anti-α<ce:inf>M</ce:inf> (OKM1) and GFP as cell sorting markers.</ce:para></ce:section><ce:section><ce:label>2.6</ce:label><ce:section-title>Cell adhesion assays</ce:section-title><ce:para>Cell adhesion was conducted using Fg or its α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-recognition domain, the γ-module <ce:cross-refs refid="bib10 bib12">[10,12]</ce:cross-refs>, based on our published procedures <ce:cross-ref refid="bib13">[13]</ce:cross-ref>.</ce:para></ce:section></ce:section><ce:section><ce:label>3</ce:label><ce:section-title>Results</ce:section-title><ce:section><ce:label>3.1</ce:label><ce:section-title>The N-terminal FERM domain of radixin interacts with the β<ce:inf>2</ce:inf> cytoplasmic tail</ce:section-title><ce:para>To see if talin is the only FERM domain-containing protein that is capable of activating integrins, we tested the ability of radixin to interact with the β<ce:inf>2</ce:inf> integrin cytoplasmic tail. Given that radixin exists in an inactive state due to an intramolecular interaction between its N- and C-terminal ERMADs <ce:cross-ref refid="bib14">[14]</ce:cross-ref>, we expressed N-ERMAD (residues 1–298) and C-ERMAD (residues 281–584) separately as either GST- or His-tagged proteins. All of the recombinant proteins exhibited expected molecular sizes and were more than 90% pure (data not shown).</ce:para><ce:para>Interactions between radixin fragments and integrin cytoplasmic tails were assessed by ELISA. Thus, 96-well microtiter plates were coated with α<ce:inf>M</ce:inf> (CYKLGFFKRQYKDMMSEGGPPGAEPQ) or β<ce:inf>2</ce:inf> (CWKALIHLSDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES) cytoplasmic peptides. Different concentrations of radixin fragments were added and bound proteins were quantified. As shown in <ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref><ce:float-anchor refid="fig1"/>A, N-ERMAD bound the β<ce:inf>2</ce:inf> cytoplasmic peptide dose-dependently with a <ce:italic>K</ce:italic><ce:inf>d</ce:inf> of 110<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>27<ce:hsp sp="0.25"/>nM, whereas no significant binding activity was observed for C-ERMAD. Moreover, neither radixin fragments interacted with the α<ce:inf>M</ce:inf> cytoplasmic peptide. Furthermore, no binding to an irrelevant peptide SW63 (CSTHFPGGGSISHSGHF) or a scrambled peptide sCTΔ31 (CLYRLEWFHAILRSRKD) was observed for N-ERMAD (data not shown), verifying the specificity of the binding assay. These data demonstrated that radixin recognizes the β<ce:inf>2</ce:inf> integrin cytoplasmic tail via its N-terminal FERM domain.</ce:para></ce:section><ce:section><ce:label>3.2</ce:label><ce:section-title>Inhibition of N-ERMAD binding to integrin cytoplasmic domain by C-ERMAD</ce:section-title><ce:para>To see if N-ERMAD binding to the integrin β<ce:inf>2</ce:inf> cytoplasmic domain is controlled by C-ERMAD, we conducted the above binding assays in the presence of His-tagged C-ERMAD. Addition of C-ERMAD at ratios of 2:1 and 4:1 (C-ERMAD:N-ERMAD) both led to significant inhibition on N-ERMAD binding to the β<ce:inf>2</ce:inf> cytoplasmic peptide (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>B). As expected, N-ERMAD did not interact with the α<ce:inf>M</ce:inf> cytoplasmic tail with or without C-ERMAD.</ce:para></ce:section><ce:section><ce:label>3.3</ce:label><ce:section-title>Radixin binds to the membrane-proximal region of the integrin β<ce:inf>2</ce:inf> cytoplasmic tail</ce:section-title><ce:para>To localize the functional sequence within the integrin β<ce:inf>2</ce:inf> cytoplasmic tail for radixin recognition, we tested N-ERMAD binding to truncated β<ce:inf>2</ce:inf> cytoplasmic peptides (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref><ce:float-anchor refid="fig2"/>A). We found that removal of NPxY/F, the sequence recognized by talin, did not significantly affect N-ERMAD binding as both truncated β<ce:inf>2</ce:inf> peptides CTΔ19 and CTΔ31 bound N-ERMAD well (<ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>B). In fact, they exhibited higher binding activity toward N-ERMAD than the full length peptide. Verifying specificity, N-ERMAD did not bind to either the scrambled peptide sCTΔ31 or BSA-coated wells.</ce:para><ce:para>To further confirm the involvement of the membrane-proximal region of the β<ce:inf>2</ce:inf> cytoplasmic tail in radixin recognition, the ability of soluble CTΔ31 to inhibit N-ERMAD binding of the full length β<ce:inf>2</ce:inf> cytoplasmic peptide was tested. Thus, N-ERMAD was added to β<ce:inf>2</ce:inf> peptide-coated 96-well plates in the presence of different concentrations of CTΔ31. After washing, bound N-ERMAD was determined as above. <ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>C shows that CTΔ31, which contains only the membrane-proximal 16 residues, competed effectively with the full length β<ce:inf>2</ce:inf> peptide for radixin binding with a C<ce:inf>50</ce:inf> of 25<ce:hsp sp="0.25"/>μM, whereas its scrambled control peptide sCTΔ31 or DMSO had no effect. Together, these data demonstrated that the NPxY/F sequence within the β<ce:inf>2</ce:inf> cytoplasmic domain, which is critical to talin recognition, is not required for radixin binding.</ce:para></ce:section><ce:section><ce:label>3.4</ce:label><ce:section-title>Radixin and cytohesin-1 recognize overlapping binding sites within the β<ce:inf>2</ce:inf> cytoplasmic tail</ce:section-title><ce:para>Cytohesin-1 activates α<ce:inf><ce:italic>L</ce:italic></ce:inf>β<ce:inf>2</ce:inf> by binding to residues 723–731 of β<ce:inf>2</ce:inf> <ce:cross-ref refid="bib15">[15]</ce:cross-ref>. To see if cytohesin-1 and radixin share a common recognition site within β<ce:inf>2</ce:inf>, we conducted additional binding experiments. <ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref><ce:float-anchor refid="fig3"/>A shows that cytohesin-1 binding to the full length β<ce:inf>2</ce:inf> peptide was effectively inhibited by soluble CTΔ31 in a dose- dependent manner, whereas additions of similar concentrations of DMSO or an irrelevant peptide SW63 had no effect and addition of (sCTΔ31) yielded much weaker inhibition.</ce:para><ce:para>To further confirm that radixin and cytohesin-1 recognize an overlapping site within the β<ce:inf>2</ce:inf> cytoplasmic tail, we tested if radixin and cytohesin-1 could compete directly with each other for binding to the β<ce:inf>2</ce:inf> cytoplasmic peptide. We found that indeed cytohesin-1 competed with radixin N-ERMAD effectively with a C<ce:inf>50</ce:inf> of 0.2<ce:hsp sp="0.25"/>μM, whereas addition of BSA did not have significant effect (<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref>B).</ce:para></ce:section><ce:section><ce:label>3.5</ce:label><ce:section-title>Radixin binds integrin α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> in total cell lysates</ce:section-title><ce:para>To test if radixin interacts with integrin receptors in whole cell lysates, we carried out pull-down experiments between radixin N-ERMAD and α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>, a major β<ce:inf>2</ce:inf> integrin expressed on leukocytes. <ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref><ce:float-anchor refid="fig4"/>A shows that radixin N-ERMAD but not GST, both of which were immobilized onto glutathione–Sepharose resin, could effectively pull down α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>, as demonstrated by the presence of a 95<ce:hsp sp="0.25"/>kDa protein by immunoblot using anti-β<ce:inf>2</ce:inf> polyclonal antibody. Additional immunoblot analyses of the pull-down products with anti-GST antibody verified that equally amount of GST and GST-N-ERMAD were present on the resin.</ce:para></ce:section><ce:section><ce:label>3.6</ce:label><ce:section-title>Radixin promotes integrin adhesive activity</ce:section-title><ce:para>To test if radixin binding to the β<ce:inf>2</ce:inf> cytoplasmic domain could result in integrin activation, we transfected N-ERMAD or C-ERMAD of radixin into α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-expressing CHO cells, using the retroviral vector MGIN <ce:cross-ref refid="bib7">[7]</ce:cross-ref>. Stable cell lines that express equivalent levels of α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> on the cell surface and similar levels of radixin were established by cell sorting using both the α<ce:inf>M</ce:inf>-specific mAb OKM1 and GFP as markers. Surface expression of α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> by the different clones and also pools of the α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>/radixin/CHO cells used in this study differed by less than twofold (mean fluorescence intensity: 1594 for GFP, 1433 for C-ERMAD pool, 1035 for N-ERMAD clone 6, and 2555 for N-ERMAD pool). Cell adhesion experiments demonstrated that expression of radixin N-ERMAD in α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>/CHO cells significantly increased the adhesive activity of α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> toward the Fg γ-module, a representative α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> ligand (<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>B). Expression of radixin N-ERMAD increased the number of adherent α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>/CHO cells more than threefold when compared to that of GFP (radixin vs. GFP, <ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.005), whereas expression of radixin C-ERMAD had no effect (<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>C). Verifying specificity of the adhesion assays, addition of EDTA or NIF, a high affinity α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-specific inhibitor <ce:cross-ref refid="bib9">[9]</ce:cross-ref>, completely blocked the α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-mediated cell adhesion. Moreover, no significant adhesion to the Fg γ-module was observed for mock-transfected CHO cells (<ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>C). Finally, to investigate whether radixin N-ERMAD promoted the adhesive activity of α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> by changing its conformation, we conducted FACS analyses using an activation-specific mAb (mAb 24), which has been used previously by us <ce:cross-refs refid="bib16 bib17">[16,17]</ce:cross-refs> and others <ce:cross-refs refid="bib8 bib18">[8,18]</ce:cross-refs> to probe the activation status of α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>. <ce:cross-ref refid="fig4">Fig. 4</ce:cross-ref>D shows that expression of radixin N-ERMAD significantly increased mAb 24 binding to α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>0.002), suggesting that in the presence of radixin N-ERMAD α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf> exists in an active conformation. Thus, radixin N-ERMAD most likely enhanced α<ce:inf>M</ce:inf>β<ce:inf>2</ce:inf>-mediated cell adhesion by activating the receptor.</ce:para></ce:section></ce:section><ce:section><ce:label>4</ce:label><ce:section-title>Discussion</ce:section-title><ce:para>Talin is the only known FERM-containing protein capable of integrin activation <ce:cross-ref refid="bib1">[1]</ce:cross-ref>. In this study, we identified another FERM domain-containing protein radixin that exhibits similar integrin activation capability. Compared to talin, radixin exhibits two distinct features: first, unlike talin, radixin recognizes the membrane-proximal region but not the NPxY/F sequence within the integrin β cytoplasmic tail; and second, talin but not radixin, is sensitive to calpain proteolysis and activation <ce:cross-ref refid="bib19">[19]</ce:cross-ref>. Thus, radixin may function as a talin-independent integrin activation pathway under specific settings.</ce:para><ce:para>Radixin interacts with the cytoplasmic domains of a number of cell surface proteins, including ICAM-1, ICAM-2, ICAM-3, CD44, and CD43 <ce:cross-refs refid="bib20 bib21">[20,21]</ce:cross-refs>. Though no consensus sequences among these different cytoplasmic domains have been identified for radixin binding, most of the known radixin recognition sequences reside within the membrane-proximal regions and contain clusters of hydrophobic and positively charged residues <ce:cross-ref refid="bib21">[21]</ce:cross-ref>. Indeed, results from this study demonstrate that radixin binds to the membrane-proximal region of integrin β<ce:inf>2</ce:inf>, which shares a significant homology with the radixin-recognition sequence within ICAM-2, especially surrounding those resides (shown in boxes, <ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref><ce:float-anchor refid="fig5"/>A) that are in direct contacts with the PTB/F3 domain of radixin (<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>B) <ce:cross-ref refid="bib22">[22]</ce:cross-ref>. Accordingly, we hypothesize that the LxxLxxYRRF sequence within the β<ce:inf>2</ce:inf> cytoplasmic domain, a sequence that is homologous to the radixin-binding site (YxxLxxWRRL) within ICAM-2, represents the major recognition site for radixin (<ce:cross-ref refid="fig5">Fig. 5</ce:cross-ref>B, conserved residues are shown in balls and sticks). Experiments to test this hypothesis are under way.</ce:para><ce:para>In summary, using a number of different approaches, we have established radixin as an important player in integrin activation. Our data demonstrate that radixin is capable of binding and activating the β<ce:inf>2</ce:inf> integrin receptor, thus identifying radixin as the second FERM-containing protein, in addition to talin, that supports integrin “inside-out” signaling. As radixin and talin recognize different regions of the integrin cytoplasmic tail, and are activated by independent intracellular signaling pathways, for example, radixin is activated by Rho-dependent kinase (ROCK) <ce:cross-ref refid="bib23">[23]</ce:cross-ref> and phosphatidylinositol 4-phosphate 5-kinase <ce:cross-ref refid="bib24">[24]</ce:cross-ref>, whereas talin is primarily activated by calpain-mediated cleavage <ce:cross-ref refid="bib2">[2]</ce:cross-ref>, radixin may represent a novel talin-independent pathway for integrin activation under specific settings.</ce:para></ce:section></ce:sections><ce:acknowledgment xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Acknowledgments</ce:section-title><ce:para>We thank Drs. Hawley, Medved, Hogg and Plow for providing valuable reagents. This work was supported in part by grants (R01 HL61589 and P01 HL54710) from the National Institutes of Health.</ce:para></ce:acknowledgment></body><tail><ce:bibliography xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>[1]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tadokoro</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Shattil</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Eto</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Tai</ce:surname></sb:author><sb:author><ce:given-name>R.C.</ce:given-name><ce:surname>Liddington</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>de Pereda</ce:surname></sb:author><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Ginsberg</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Calderwood</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Talin binding to integrin beta tails: a final common step in integrin activation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>302</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>103</sb:first-page><sb:last-page>106</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>[2]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Yan</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Calderwood</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Yaspan</ce:surname></sb:author><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Ginsberg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>28164</sb:first-page><sb:last-page>28170</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>[3]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Martel</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Racaud-Sultan</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Dupe</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Marie</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Paulhe</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Galmiche</ce:surname></sb:author><sb:author><ce:given-name>M.R.</ce:given-name><ce:surname>Block</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Albiges-Rizo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>21217</sb:first-page><sb:last-page>21227</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>[4]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Rees</ce:surname></sb:author><sb:author><ce:given-name>S.E.</ce:given-name><ce:surname>Ades</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Singer</ce:surname></sb:author><sb:author><ce:given-name>R.O.</ce:given-name><ce:surname>Hynes</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sequence and domain structure of talin</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>347</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>685</sb:first-page><sb:last-page>689</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>[5]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Calderwood</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Yan</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>de Pereda</ce:surname></sb:author><sb:author><ce:given-name>B.G.</ce:given-name><ce:surname>Alvarez</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Fujioka</ce:surname></sb:author><sb:author><ce:given-name>R.C.</ce:given-name><ce:surname>Liddington</ce:surname></sb:author><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Ginsberg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The phosphotyrosine binding-like domain of talin activates integrins</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>277</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>21749</sb:first-page><sb:last-page>21758</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>[6]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>P.E.</ce:given-name><ce:surname>Hughes</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Diaz-Gonzalez</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Leong</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Wu</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>McDonald</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Shattil</ce:surname></sb:author><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Ginsberg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Breaking the integrin hinge. A defined structural constraint regulates integrin signaling</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>271</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>6571</sb:first-page><sb:last-page>6574</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>[7]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Cheng</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Du</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Murray</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Tong</ce:surname></sb:author><sb:author><ce:given-name>Y.A.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>B.P.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>R.G.</ce:given-name><ce:surname>Hawley</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Gene Ther.</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1013</sb:first-page><sb:last-page>1022</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>[8]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Dransfield</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Hogg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Regulated expression of Mg<ce:sup>2+</ce:sup> binding epitope on leukocyte integrin alpha subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>3759</sb:first-page><sb:last-page>3765</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>[9]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>P.J.</ce:given-name><ce:surname>Muchowski</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>E.R.</ce:given-name><ce:surname>Chang</ce:surname></sb:author><sb:author><ce:given-name>H.R.</ce:given-name><ce:surname>Soule</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Plow</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Moyle</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD1 1b/CD18</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>269</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>26419</sb:first-page><sb:last-page>26423</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>[10]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Plow</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Overlapping, but not identical, sites are involved in the recognition of C3bi, neutrophil inhibitory factor, and adhesive ligands by the alphaMbeta2 integrin</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>271</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>18211</sb:first-page><sb:last-page>18216</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>[11]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Cao</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Lawrence</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>C.A.</ce:given-name><ce:surname>von Arnim</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Herz</ce:surname></sb:author><sb:author><ce:given-name>E.J.</ce:given-name><ce:surname>Su</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Makarova</ce:surname></sb:author><sb:author><ce:given-name>B.T.</ce:given-name><ce:surname>Hyman</ce:surname></sb:author><sb:author><ce:given-name>D.K.</ce:given-name><ce:surname>Strickland</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1860</sb:first-page><sb:last-page>1870</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>[12]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.P.</ce:given-name><ce:surname>Ugarova</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Solovjov</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>D.I.</ce:given-name><ce:surname>Loukinov</ce:surname></sb:author><sb:author><ce:given-name>V.C.</ce:given-name><ce:surname>Yee</ce:surname></sb:author><sb:author><ce:given-name>L.V.</ce:given-name><ce:surname>Medved</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Plow</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>273</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>22519</sb:first-page><sb:last-page>22527</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>[13]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Lawrence</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sequences within domain II of the urokinase receptor critical for differential ligand recognition</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>278</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>29925</sb:first-page><sb:last-page>29932</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>[14]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Magendantz</ce:surname></sb:author><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Henry</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Lander</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Solomon</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Interdomain interactions of radixin in vitro</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>270</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>25324</sb:first-page><sb:last-page>25327</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>[15]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Geiger</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Nagel</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Boehm</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>van Kooyk</ce:surname></sb:author><sb:author><ce:given-name>C.G.</ce:given-name><ce:surname>Figdor</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Kremmer</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Hogg</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zeitlmann</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Dierks</ce:surname></sb:author><sb:author><ce:given-name>K.S.</ce:given-name><ce:surname>Weber</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Kolanus</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cytohesin-1 regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with LFA-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>2525</sb:first-page><sb:last-page>2536</sb:last-page></sb:pages></sb:host><sb:comment>JID-8208664</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>[16]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Ehirchiou</ce:surname></sb:author><sb:author><ce:given-name>Y.M.</ce:given-name><ce:surname>Xiong</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Brew</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Dual function for a unique site within the beta2I domain of integrin alphaMbeta2</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>280</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>8324</sb:first-page><sb:last-page>8331</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>[17]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>Y.M.</ce:given-name><ce:surname>Xiong</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Modulation of CD11b/CD18 adhesive activity by its extracellular, membrane-proximal regions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Immunol.</sb:maintitle></sb:title><sb:volume-nr>171</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>1042</sb:first-page><sb:last-page>1050</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>[18]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Lu</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Shimaoka</ce:surname></sb:author><sb:author><ce:given-name>Q.</ce:given-name><ce:surname>Zang</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Takagi</ce:surname></sb:author><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Springer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Locking in alternate conformations of the integrin alpha Lbeta 2 I domain with disulfide bonds reveals functional relationships among integrin domains</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>2393</sb:first-page><sb:last-page>2398</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>[19]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Shcherbina</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Bretscher</ce:surname></sb:author><sb:author><ce:given-name>D.M.</ce:given-name><ce:surname>Kenney</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Remold-O’Donnell</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FEBS Lett.</sb:maintitle></sb:title><sb:volume-nr>443</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>31</sb:first-page><sb:last-page>36</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>[20]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Oishi</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Sato</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Sagara</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Kawai</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>126</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>391</sb:first-page><sb:last-page>401</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>[21]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yonemura</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Hirao</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Doi</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Takahashi</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kondo</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>140</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>885</sb:first-page><sb:last-page>895</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>[22]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hamada</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Shimizu</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yonemura</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Hakoshima</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>502</sb:first-page><sb:last-page>514</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>[23]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Matsui</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Maeda</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Doi</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yonemura</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Amano</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Kaibuchi</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Cell. Biol.</sb:maintitle></sb:title><sb:volume-nr>140</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>647</sb:first-page><sb:last-page>657</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>[24]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Matsui</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yonemura</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Tsukita</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Biol.</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>1259</sb:first-page><sb:last-page>1262</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article>
